Docetaxel (docetaxel anhydrous) NDC 25021-245

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-245Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0245Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-245-01	25021024501	1 VIAL in 1 CARTON (25021-245-01) / 1 mL in 1 VIALMarketed from Sep 15, 2017
25021-245-04	25021024504	1 VIAL in 1 CARTON (25021-245-04) / 4 mL in 1 VIALMarketed from Sep 15, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Docetaxel
Generic name (nonproprietary): docetaxel anhydrous
Active ingredients: Docetaxel anhydrous — 20 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207252
Marketing start: Sep 15, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Microtubule Inhibition (Physiologic effect)
Identifiers: Product ID 25021-245_3897fe0d-2b9f-4be0-9076-9ccd693d4c86SPL ID 3897fe0d-2b9f-4be0-9076-9ccd693d4c86SPL set ID 30077f79-341f-4618-9ec5-23b17b212faeRxCUI 1860480, 1860485UNII 699121PHCA
Pharmacologic class: Microtubule Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021024501 followed by a unit qualifier and the quantity

Package 25021-0245-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207252

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207252
Product	Strength	Form · route	Labeler	Product NDC
Docetaxel	Docetaxel 160 mg/8mL	Injection, Solution, ConcentrateIntravenous	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	57884-3043
Docetaxel	Docetaxel 20 mg/mL	Injection, Solution, ConcentrateIntravenous	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	57884-3041
Docetaxel	Docetaxel 80 mg/4mL	Injection, Solution, ConcentrateIntravenous	Jiangsu Hengrui Pharmaceuticals Co., Ltd.	57884-3042